News and business features – Page 4
-
News
US programme targeting researchers with China links crumbling under intense scrutiny
Academics are demanding that the Justice Department end the ‘China Initiative’ as cases collapse amid accusations of racial profiling
-
News
Merkel era ends leaving German science with a bright future
Outgoing German chancellor’s background in chemistry and physics gave her unique insight into the importance of stable funding
-
Business
The future of ‘next generation’ DNA sequencing
As it gets cheaper and easier to read genetic code, its applications are expanding rapidly
-
News
Science and research ‘are dead’ in Afghanistan
Afghan researchers and scholars flee or go into hiding as the Taliban’s return to power sees the science academy and universities closed
-
Business
The multi-pronged search for Covid-19 treatments
Drugs that block infection or reduce inflammation will complement vaccine protection
-
News
Research and regulations face-up to a new era of non-animal testing alternatives
Hopes raised that approval for skin sensitisation test could mark the start of a raft of in vitro toxicity tests
-
Business
Industry tightens emissions reduction targets
As COP26 approaches, many firms are announcing ambitious climate goals. But are they achievable?
-
News
Inside the clean-up of last year’s deadly Beirut blast
German firms hired to handle the 59 contaminated containers in Beirut’s port found hydrochloric, sulfuric, hydrofluoric acids, and more
-
News
Race to understand Sars-CoV-2 variants amid fears virus might evade vaccines
Biochemical basis behind coronavirus variants’ success could hold key to defeating them
-
Business
Searching for more sustainable resin materials
Paul Jones of Bitrez is the 2021 Chemistry World Entrepreneur of the Year
-
News
Publishers grapple with an invisible foe as huge organised fraud hits scientific journals
Hundreds of fake research manuscripts from paper mills have flooded biochemical and biomedical journals in recent years. But how do you stop large-scale fraud barely anything is known about?
-
Business
What might UK Reach look like?
As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring
-
News
How Covid gave the world a lesson in tackling air pollution
The pandemic has given atmospheric chemists the opportunity to study pollution and carbon emissions like never before
-
Business
Antibody–drug conjugates drive growth in oncology
Antibody–drug conjugates are coming of age and pharma is investing, reports Katrina Megget
-
Business
Why manufacturing Covid vaccines at scale is hard
Exploring the pinch points vaccine makers face as they ramp up production
-
News
A decade on Japan is still grappling with the environmental impact of Fukushima
Decontamination efforts appear to have been effective, but concerns remain about disposal of contaminated soil and water, as well as the need for long-term future monitoring
-
Business
Covid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
News
Decoding the virus – what we know about Sars-CoV-2 a year on
Scientists have never learnt so much about a pathogen in such a short time
-
News
Biden thrills US research community with his science ‘dream team’
The new US president has elevated the role of science in the White House
-
Business
Can chemistry thaw the vaccine cold chain?
Covid-19 has highlighted the challenges of storing vaccines at their proper temperature. Angeli Mehta explores how scientists are trying to protect vaccines from heat degradation